Medindia
To Take Care of Your Diabetes Click Here
Medindia » Health Watch

Quality Concerns Surround Indian Cough Syrup Linked to Child Deaths

by Dr. Krishanga on December 6, 2023 at 3:10 PM
Listen to this News

Highlights:

"In the pursuit of affordable drugs, the cost of compromise proves too high. Riemann Labs' case raises critical questions about the global pharmaceutical supply chain."


Unidentified quality issues have been discovered in at least one of the five samples of a cough syrup tested by Indian authorities, according to two sources familiar with the investigation. This cough syrup, manufactured by Riemann Labs, has been linked to the deaths of at least six children in Cameroon (1).

Cough Syrups Associated with the Deaths of 141 Children

Riemann Labs is one of three Indian drugmakers whose cough syrups have been associated with the deaths of 141 children in Gambia, Uzbekistan, and Cameroon since the middle of the previous year. This has raised concerns about the quality of drug exports from India, often referred to as the "world's pharmacy" for its supply of affordable life-saving drugs to countries in need.

WHO's Report on Cough Syrup

In July, the World Health Organization (WHO) reported that a sample of Naturcold syrup from Cameroon, identified as Riemann's product, contained up to 28.6% of the toxin diethylene glycol, exceeding the acceptable limit of 0.10%.

‘At least 28.6% toxin found in Naturcold syrup, exposing quality lapses in Indian exports. #drugsafety #riemanncontroversy #medindia’

In response to the WHO alert, Indian authorities suspended Riemann's production, citing violations of good manufacturing practices. Subsequently, five Naturcold samples were sent for testing, and at least one of them was found to be of "not of standard" quality, as per the anonymous sources.

The specific issues with the sample were not disclosed by the sources, who preferred to remain unnamed due to the sensitivity of the matter. Riemann Labs and the drug regulator of Madhya Pradesh state, where the company is located, did not respond to Reuters' queries.

An inspection of Riemann's factory in June by state and federal regulators revealed violations, including improper ventilation that increased the risk of cross-contamination.

Riemann reportedly informed the state regulator that it was undertaking repairs to resume production. Other Indian cough syrup manufacturers implicated in overseas deaths have also applied to reopen their factories.

Since June, India has made testing mandatory for cough syrup exports and intensified scrutiny of drugmakers, uncovering various deficiencies in recent inspections, such as poor documentation and a lack of self-assessment.

Reference:

  1. WHO urges action to protect children from contaminated medicines - (https:www.who.int/news/item/23-01-2023-who-urges-action-to-protect-children-from-contaminated-medicines)

Source: Medindia

Cite this Article

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Dr. Krishanga. (2023, December 06). Quality Concerns Surround Indian Cough Syrup Linked to Child Deaths. Medindia. Retrieved on Nov 24, 2024 from https://www.medindia.net/news/healthwatch/quality-concerns-surround-indian-cough-syrup-linked-to-child-deaths-214425-1.htm.

  • MLA

    Dr. Krishanga. "Quality Concerns Surround Indian Cough Syrup Linked to Child Deaths". Medindia. Nov 24, 2024. <https://www.medindia.net/news/healthwatch/quality-concerns-surround-indian-cough-syrup-linked-to-child-deaths-214425-1.htm>.

  • Chicago

    Dr. Krishanga. "Quality Concerns Surround Indian Cough Syrup Linked to Child Deaths". Medindia. https://www.medindia.net/news/healthwatch/quality-concerns-surround-indian-cough-syrup-linked-to-child-deaths-214425-1.htm. (accessed Nov 24, 2024).

  • Harvard

    Dr. Krishanga. 2023. Quality Concerns Surround Indian Cough Syrup Linked to Child Deaths. Medindia, viewed Nov 24, 2024, https://www.medindia.net/news/healthwatch/quality-concerns-surround-indian-cough-syrup-linked-to-child-deaths-214425-1.htm.

View Non AMP Site | Back to top ↑